GH Research PLC (GHRS)

GH Research PLC is a cutting-edge clinical-stage biopharmaceutical company focused on developing transformative psilocybin-based therapies for psychiatric and neurodegenerative disorders. With a promising pipeline of drug candidates, the company aims to fulfill significant unmet needs in mental health care, leveraging the expertise of a skilled team committed to advancing scientific innovation. GH Research's pioneering initiatives are set to redefine treatment paradigms and enhance patient outcomes, establishing it as a potential leader in the rapidly evolving field of mental health therapeutics.